NUTRITION AND TUBERCULOSIS

(Sharma & Mohan Textbook of Tuberculosis, Chapter 40 — Subbaraman & Andrews)

INTRODUCTION

I. IMPACT OF NUTRITION ON THE RISK OF ACTIVE TUBERCULOSIS

A. Mechanisms (Animal Model Evidence)

• Protein-malnourished guinea pigs exhibit absolute and relative deficiencies in T-lymphocyte subsets: CD2+, CD4+, and CD8+ cells.
• After BCG vaccination, protein-deficient animals showed markedly decreased tuberculin skin test (TST) and interferon-γ assay responses compared to protein-replete animals.
• Lymphocyte transfer experiments: Lymphocytes from TB-infected, protein-deficient animals failed to protect well-nourished animals from TB. Conversely, lymphocytes from well-nourished TB-infected animals protected protein-deficient animals — proving that protein status directly modulates the lymphocytic immune response to TB.
• Improvement in protein-related nutritional status led to significant reduction in active TB risk, suggesting partial recovery of TB-specific immune response with reversal of malnutrition.
• In contrast, vitamin D and zinc deficiencies alone were not associated with increased TB risk in animal models.

B. Epidemiological Evidence

1. WWII Prisoner-of-War Study (Leyton 1946): Russian POWs on near-starvation rations had a 19% rate of pulmonary TB vs. only 1.2% in relatively well-fed British POWs — a 16-fold increased relative risk attributable to undernourishment. Crucially, rates of malaria and dysentery were similar in both groups, confirming TB had the strongest nutritional association. The character of disease also differed: Russians showed rapidly progressive fatal infection with little granuloma formation; British soldiers showed a normal chronic course.
2. Norwegian Naval Recruits (1940s): TB rates among recruits fell only after heavy dietary supplementation with milk, cod liver oil, fruits, and vegetables — improvements in hygiene and housing alone had failed to reduce rates.
3. Papworth Village Settlement, England (1918–1943): Children born inside the settlement (adequate nutrition and housing) had a much lower incidence of TB than those born outside.

• Mumbai Cohort Study (148,173 adults, 6-year follow-up): For severely underweight individuals (BMI <16), the adjusted relative risk of TB death was 7-fold in men and 14-fold in women compared to normal BMI. Even mild-to-moderate underweight significantly increased risk; overweight and obesity were protective.
• US NHANES (1971–1992): Underweight individuals (BMI <18.5) had an adjusted hazard ratio of 12.4 for developing TB.
• Systematic review (6 prospective cohort studies): A consistent inverse log-linear relationship between TB incidence and BMI — each 1-unit increase in BMI is associated with an average 13.8% reduction in TB incidence.
• Vegetarian diet and TB risk: Two studies of South Asian immigrants in Britain found vegetarianism correlated with a 3–4-fold increased TB risk, with a dose-response relationship: decreasing meat consumption correlated with increasing TB risk. Increased fruit, vegetable, and berry intake was protective.

II. IMPACT OF ACTIVE TUBERCULOSIS ON NUTRITION

A. Weight Loss and Protein-Energy Malnutrition

• BMI, skinfold thickness, mid-upper arm circumference (MUAC), grip strength
• Body fat percentage, calorie stores, muscle mass
• Serum albumin, haemoglobin, plasma retinol, plasma zinc, selenium, iron
• Vitamins A, C, D, and E

• The predominant biochemical driver is elevated TNF-α, which causes a net catabolic state.
• An "anabolic block" (decrease in protein synthesis) has been described, though findings are conflicting.
• Albumin and prealbumin are useful markers both for diagnosing deficiency and monitoring its reversal.
• Leptin does not appear to be involved in TB-associated wasting.
• Plasma peptide YY may modulate appetite suppression and is associated with poor prognosis.

B. Micronutrient Deficiencies

C. Wasting in HIV/TB Co-infected Individuals

• Both HIV and TB independently cause wasting; their combination produces profound cachexia that is more severe than either disease alone for all nutritional indicators: BMI, arm circumference, albumin, vitamin A.
• TB is the predominant cause of severe wasting in HIV-infected patients in endemic regions.
• The two diseases synergistically cause anaemia, with major impacts on functional status and mortality.
• Untreated HIV may blunt the nutritional recuperation that normally occurs during TB treatment.

III. NUTRITION AND NATURAL HISTORY OF TUBERCULOSIS

A. Disease Manifestations

• Less likely: haemoptysis, upper lobe cavitation
• More likely: dyspnoea, diarrhoea, lower lobe consolidation, miliary nodules, mediastinal lymphadenopathy
• This pattern parallels TB in AIDS patients, suggesting T-lymphocyte-associated immunodeficiency as a common pathway.

B. Mortality and Treatment Outcomes

• Malnutrition independently associated with:
  • Increased mortality
  • Higher rates of treatment failure and relapse
  • Worse outcomes in MDR-TB patients
• Initial body weight or BMI at TB diagnosis is a powerful prognostic indicator — at times predicting survival better than complex scores like APACHE.
• Lean tissue mass wasting is independently associated with increased mortality risk (especially in women).
• Malnourished patients more likely to have sub-therapeutic drug levels and drug-induced hepatotoxicity.
• Diabetes comorbidity (meta-analysis): pooled relative risk of treatment failure+death = 1.69; pooled odds of death alone (adjusted) = 5-fold increased.

C. Nutritional Recovery

• Chemotherapy interrupts progressive wasting.
• Reduction in bacillary burden → decline in peptide YY and ghrelin → rise in appetite → increase in body fat and BMI.
• "Nutritional partitioning": patients gain ~10% body weight in first 6 months but recovery is predominantly fat mass with minimal improvement in protein stores or bone mineralisation.

• 80% of HIV-TB co-infected patients remain underweight after completing anti-TB therapy (Chennai study).

• Diabetes blunts nutritional recovery further (Tanzanian cohort).

IV. NUTRITION AND DIAGNOSTIC TESTS

A. Tuberculin Skin Test (TST)

• Malnutrition decreases TST sensitivity — low biometric indicators, low albumin, and deficiencies of vitamin D and zinc are associated with decreased TST reaction size (risk of false negatives).
• Clinicians should err on the side of liberally interpreting borderline TST reactions in undernourished patients.

B. IGRA (Interferon-γ Release Assays)

• Sensitivity of IGRAs is also significantly decreased in malnourished patients — important clinical consideration.

C. BCG Vaccine

1. Ongoing nutritional maintenance is critical for continued vaccine-induced immune protection. Even mild malnutrition results in fewer positive TSTs after BCG vaccination, suggesting nutritional state modulates vaccine-induced immunity over time.
2. Severe protein malnutrition at time of BCG administration can permanently impair vaccine-induced immune protection — children with kwashiorkor at vaccination had very high rates of negative TSTs even after nutritional recovery.
3. Implication: Severely protein-malnourished children may benefit from nutritional repletion prior to BCG vaccination if feasible.

V. ISONIAZID AND VITAMIN B6 (PYRIDOXINE) DEFICIENCY

VI. NUTRITIONAL INTERVENTIONS FOR TB PATIENTS

A. Summary Table of Critical Nutritional Considerations (Table 40.1, Sharma & Mohan)

B. Macronutrient Interventions

• Classic Chennai Sanatorium Trial (late 1950s): 193 patients randomised to home vs. sanatorium treatment (sanatorium provided significantly higher caloric, protein, and micronutrient intake). Despite markedly more weight gain in sanatorium patients, overall TB treatment response was similar — none of the dietary factors significantly influenced time to culture-negative sputum or radiographic improvement.
• Subsequent small studies evaluating cereals/lentils, high-calorie nuts, ghee, high-calorie packaged supplements, peanuts, and comprehensive meals showed:
  • Mixed results for TB treatment outcomes (sputum conversion, treatment failure)
  • Consistent increases in weight gain across virtually all studies
  • Significant increases in lean body mass, grip strength, and quality-of-life scores in some studies
• Even with supplementation, patients did not reach the minimum 2,500 kcal/day — TB patients may need even higher intakes given the profound catabolic state.

C. Vitamin D Supplementation

• Historical context: cod-liver oil (high in vitamin D) was used in mid-1800s for TB. Sunlight for lupus vulgaris (cutaneous TB) won Niels Finsen the Nobel Prize in 1895.
• VDR activation by vitamin D → enhances macrophage phagocytic activity → induces cathelicidin (antimicrobial peptide) → kills Mtb.
• VDR gene polymorphisms (FokI, BsmI, TaqI, ApaI) influence individual TB risk and therapeutic responses, especially in Asian populations.
• Trial results:
  • Low-dose (5,000 IU/day) or intermittent high-dose (100,000 IU every few months): no improvement in mortality or sputum conversion
  • 10,000 IU/day: statistically significant improvement in sputum smear conversion rate
  • 100,000 IU every 2 weeks × 6 weeks (Martineau RCT, Lancet 2011): Overall: no significant difference in sputum culture conversion time. However, significant benefit in patients with VDR TaqI "tt" genotype — suggesting genotype-directed vitamin D therapy may be the future approach, especially for MDR/XDR-TB.

D. Combination Micronutrient Supplementation

• Harlem RCT (1940s): Supplementation with niacin, thiamine, riboflavin, vitamins A and C, calcium, and iron for 5 years → statistically significant lower TB incidence (0.16 vs. 0.91 cases/100 person-years).
• Tanzania RCT (887 TB patients, ~50% HIV co-infected):
  • 45% reduction in TB recurrence in overall intervention group
  • 63% reduction in TB recurrence in HIV-infected subset
  • 64% reduction in mortality in HIV-negative group (did not reach significance)
  • Greatly decreased peripheral neuropathy rates
• Other studies show increased grip strength and weight gain but inconsistent evidence on treatment outcomes.

E. Vitamin A and Zinc

• Individual or combined supplementation: no improvement in mortality or treatment completion rates.
• One study: vitamin A + zinc → more rapid sputum culture conversion.
• Concerning finding: Two studies found higher mortality in HIV-infected patients receiving vitamin A + zinc supplementation — urging caution.

F. Iron Supplementation

• Iron supplementation in Odisha: accelerated improvement of anaemia in first month of TB treatment, but benefits largely disappeared by second month.

VII. DIABETES MELLITUS AND TB — A GROWING NUTRITIONAL TRANSITION THREAT

• DM associated with approximately 2-fold increased odds of active TB (some studies up to 5–7-fold).
• In India: 25% of TB patients in Tamil Nadu had diabetes + 25% had pre-diabetes by OGTT; 37% were newly detected. Only 4 TB patients needed to be screened to find 1 new diabetic — supporting universal DM screening in TB clinics.
• Kerala: 44% prevalence of diabetes among TB patients (HbA1c-based), with 47% newly diagnosed.
• Low BMI remains the greater contributor in India: 34% of TB burden in the poorest third of Indians attributable to low BMI vs. 1.3% to DM.
• However, at higher DM prevalence estimates, up to 20% of Indian TB burden may be attributable to DM.

VIII. INDIA-SPECIFIC CONTEXT: FEAST AND FAMINE

• Daily calorie consumption is at historic lows.
• Average BMI has actually decreased among already undernourished rural men.
• Between 1998 and 2008, India likely experienced a rise in TB cases disproportionate to population growth, predominantly attributable to worsening undernutrition among rural men and rising diabetes.
• Clinician's role: Addressing malnutrition in all TB patients — encouraging increased protein intake, targeted micronutrient supplementation, diabetes screening, treating intestinal parasites and anaemia, and advocating for public food security policies.

SUMMARY TABLE

TUBERCULOSIS AND NUTRITION

Condensed 15-Mark MD Exam Answer

INTRODUCTION (1 mark)

I. NUTRITION → RISK OF ACTIVE TB (3 marks)

Mechanisms of Immunosuppression

• Protein malnutrition depletes CD2+, CD4+, CD8+ T-lymphocyte subsets
• Impairs cell-mediated immunity, phagocytic function, and immunoglobulin production
• BCG-vaccinated protein-deficient animals show markedly reduced TST and IFN-γ responses
• Vitamin D/zinc deficiency alone are insufficient to increase TB risk (guinea pig models)

Epidemiological Evidence

II. ACTIVE TB → NUTRITIONAL DEPLETION (3 marks)

Weight Loss and Protein-Energy Malnutrition

• Presenting complaint in ~50% of TB patients
• All nutritional markers are depressed: BMI, MUAC, grip strength, albumin, haemoglobin, vitamins A/C/D/E, zinc, iron, selenium
• Weight loss is predominantly fat mass, but loss of lean (fat-free) mass has greater impact on function

• ↑ TNF-α → net catabolic state (predominant mechanism)
• "Anabolic block" (↓ protein synthesis) — described but debated
• Albumin/prealbumin = best markers for monitoring nutritional status; albumin improvement = earliest sign of recovery

Micronutrient Deficiencies

HIV-TB Co-infection

• Synergistic cachexia — worse than either disease alone for all nutritional parameters
• TB is the predominant cause of wasting in HIV patients in endemic regions
• Synergistic anaemia → major impact on mortality

• 80% of HIV-TB co-infected patients remain underweight even after completing anti-TB therapy (Chennai)

III. NUTRITION EFFECTS ON TB NATURAL HISTORY (2 marks)

Atypical Presentations in Malnutrition

Prognostic Impact

• Malnutrition independently associated with ↑ mortality, ↑ treatment failure, ↑ relapse
• BMI at diagnosis predicts survival better than APACHE score in some studies
• Diabetes + TB: pooled OR for death = 5×; treatment failure+death RR = 1.69

Nutritional Recovery During Treatment

• Chemotherapy reduces bacillary burden → peptide YY ↓, ghrelin ↓ → appetite ↑
• "Nutritional partitioning": gains are mostly fat (10% BW gain in 6 months) with minimal protein/bone mineral recovery
• Diabetes blunts nutritional recovery further

IV. NUTRITION AND DIAGNOSTIC TESTS (1 mark)

Clinical implication: In severely protein-malnourished children, nutritional repletion before BCG should be considered where feasible.

V. ISONIAZID AND VITAMIN B6 DEFICIENCY (2 marks)

• Malnourished individuals
• Elderly
• Pregnant women
• Cancer patients, chronic alcoholics, chronic liver disease
• Adolescent children
• Diabetes, renal failure, HIV (especially on stavudine/didanosine)

VI. NUTRITIONAL INTERVENTIONS IN ACTIVE TB (2 marks)

A. Macronutrient Supplementation

• Classic Chennai Sanatorium Trial (1950s): Despite markedly greater weight gain in sanatorium (supplemented) patients, overall TB treatment response was identical between supplemented and home-treated groups
• Subsequent trials (nuts, ghee, high-calorie packs, arginine-rich peanuts): consistent weight gain and improved quality-of-life, inconsistent improvement in sputum conversion/treatment outcomes
• Minimum 2,500 kcal/day recommended — TB patients may need even more due to catabolic state

B. Vitamin D

Future implication: Genotype-directed high-dose vitamin D supplementation — particularly relevant for MDR/XDR-TB where chemotherapy options are limited.

C. Combination Micronutrient Supplementation

• Tanzania RCT (887 patients, ~50% HIV+): Multivitamin supplementation →
  • 45% reduction in TB recurrence overall
  • 63% reduction in HIV+ subgroup
  • 64% reduction in HIV-negative mortality (NS)
  • Greatly reduced peripheral neuropathy rates
• Other trials: improved grip strength and weight gain; inconsistent effects on outcomes

D. Vitamin A + Zinc

• No improvement in mortality or treatment completion
• Caution: Two studies showed higher mortality in HIV-infected patients receiving vitamin A + zinc

E. Iron

• Accelerates anaemia correction in first month; benefit largely lost by second month

VII. DIABETES AND TB — THE EMERGING THREAT (1 mark)

• DM increases active TB risk ~2-fold (some studies: 5–7×)
• Tamil Nadu survey: 25% TB patients had DM + 25% pre-DM (OGTT); 37% newly detected → Universal DM screening in TB clinics (NNS = 4 to find 1 new DM case)
• Kerala: 44% DM prevalence among TB patients (HbA1c-based)
• In India: low BMI still dominates (34% attributable TB burden in poorest third) vs. DM (1.3–20% depending on prevalence estimate)

SUMMARY BOX

VICIOUS CYCLE:
Malnutrition → ↓ CD4+/CD8+/CD2+ cells → Impaired granuloma formation
     ↑                                              ↓
     |                                      Active TB disease
     |                                              ↓
 Further nutritional                    TNF-α ↑ → Catabolism
 depletion ← ← ← ← ← ← ← ← ← ← ← ← ←  Fat + lean tissue wasting